Dietary Intake and Nutrient Status of Children With ADHD

Sponsor
University of British Columbia (Other)
Overall Status
Completed
CT.gov ID
NCT00434928
Collaborator
Eli Lilly and Company (Industry)
60
1
12
5

Study Details

Study Description

Brief Summary

Assess the dietary intake of children aged 6-12 years by means of a 24-hour recall and 3-day food record and asses the nutrient status of Vitamin B6, serum ferritin, serum zinc and serum copper of the same children by means of standard laboratory assessments.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    • To document the use of vitamin and vitamin-mineral supplements

    • To determine the percent consumption of low nutrient density (LND) foods

    • To compare the dietary intake of ADHD children with the established standards of the Dietary Reference Intakes (DRIs)

    • To compare the dietary intake of children with ADHD to the dietary recommendations of Canada's Food Guide for Healthy Eating

    • To determine whether dietary intake is moderated by drug treatment

    • To assess the pyridoxal-5'-phosphate (PLP), serum ferritin, serum zinc, and serum copper status of ADHD by standard laboratory blood test

    • to measure height and weight in ADHD children

    Study Design

    Study Type:
    Observational
    Observational Model:
    Defined Population
    Time Perspective:
    Prospective
    Official Title:
    Dietary Intake and Nutrient Status of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
    Study Start Date :
    Jan 1, 2006
    Study Completion Date :
    Jan 1, 2007

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      6 Years to 12 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:
      • Primary diagnosis of ADHD

      • Age 6-12 years inclusive

      Exclusion Criteria:
      • No use of medication that affects dietary intake (eg. Risperdal)

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Provincial ADHD Program, BC Children's Hospital Vancouver British Columbia Canada

      Sponsors and Collaborators

      • University of British Columbia
      • Eli Lilly and Company

      Investigators

      • Principal Investigator: Margaret D. Weiss, MD, University of British Columbia

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00434928
      Other Study ID Numbers:
      • H05-70464
      • W05-0185
      First Posted:
      Feb 14, 2007
      Last Update Posted:
      Feb 14, 2007
      Last Verified:
      Feb 1, 2007

      Study Results

      No Results Posted as of Feb 14, 2007